KEY DEADLINES
Abstract Submission Deadline: CLOSED
Early Bird Registration Deadline: 23 June 2022
Accommodation Deadline: 20 June 2022
Standard Registration Deadline: 3 July 2022
KEY DEADLINES
Abstract Submission Deadline: CLOSED
Early Bird Registration Deadline: 23 June 2022
Accommodation Deadline: 20 June 2022
Standard Registration Deadline: 3 July 2022
The committee are pleased to announce the poster listing is now available. This will continue to be updated as more details are confirmed, please note this is subject to change without notice.
Clinical Management and Therapeutics
#6 SAFETY OF REMDESIVIR VS PLACEBO IN NON-HOSPITALIZED PATIENTS WITH COVID-19
Alison Thorburn, Gilead, VIC
#7 REMDESIVIR IN AN OUTPATIENT SETTING IMPROVES BIOMARKERS FOR PROGRESSION OF COVID-19
Alison Thorburn, Gilead, VIC
#14 How do care environments shape COVID-19 healthcare?
Mia Harrison, UNSW, NSW
#40 REMDESIVIR IN THE TREATMENT OF CHILDREN 28 DAYS TO < 18 YEARS OF AGE HOSPITALIZED WITH COVID-19 IN THE CARAVAN STUDY
Alison Thorburn Gilead
#41 OUTPATIENT REMDESIVIR PREVENTS COVID-19 PROGRESSION IN HIGH-RISK PATIENTS WHEN RANDOMISED WITHIN 7 DAYS FROM SYMPTOM ONSET: SUB-ANALYSES FROM A PHASE 3 TRIAL
Alison Thorburn, Gilead, VIC
#54 EFFECT OF SEROSTATUS ON THE EFFICACY OF SOTROVIMAB IN PREVENTING COVID-19 PROGRESSION
Alberto Stella, GlaxoSmithKline, VIC
#55 Resistance Analysis in the COMET-ICE Study: Sotrovimab Treatment in Participants with Mild-to-Moderate COVID-19
Tommy Liu, GlaxoSmithKline, VIC
#76 EVALUATION OF THE SEEGENE ALLPLEX SARS COV-2 VARIANTS I ASSAY IN THE IDENTIFICATION OF SARS COV-2 OMICRON VARIANTS
Hayley Heaton, Canberra Health Services, ACT
#86 Ongoing Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine in the United Kingdom
Seth Toback, Novavax Inc, USA
#92 Covid 19 Outcomes Similar for People Living with HIV Compared with HIV Negatives in a Sydney General Practice
David Baker, East Sydney Doctors, NSW
Discovery and Translational Science
#5 Case studies on COVID-19 data management in Australia
Priyanka Pillai, The University Of Melbourne, VIC
#8 Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection
Andrew Kelly, NSW State Reference Laboratory for HIV, St Vincent’s Centre For Applied Medical Research, St Vincent’s Hospital, Sydney, NSW
#10 TOWARDS THE RAT AS A MODEL FOR COVID-19 LUNG DISEASE
Jill Carr, Flinders University, VIC
#11 BLOOD QUINOLINIC ACID AND KYNURENINE AS BIOMARKERS OF THERAPEUTIC TARGETS FOR NEUROCOVID
Bruce Brew, St. Vincent’s Hospital, NSW
#20 The COVID-19 Immune Responses Study (COVIRS)
Feargal Ryan, South Australian Health and Medical Research Institute, SA
#27 Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of Spike RBD-specific memory B cells to variants-of-concern
Gemma Hartley, Monash University, VIC
#46 Impact of differential gene expression on early innate immune responses to COVID-19 vaccination in end stage renal disease patients and healthy controls
Shanelle Gingras, University Of Manitoba, USA
#59 Novel siRNA therapeutics targeting conserved regions across SARS-CoV-2 variants of concern demonstrate strong broad protection
Ellen Bowden-Reid The Kirby Institute, UNSW, NSW
#70 Acceptability of self rapid antigen testing in the community at home (SCRATCH)
Jacqueline Prestedge Peter Doherty Institute for Infection and Immunity
#106 A naturally occurring human SARS-CoV-2 variant has an increased affinity for murine ACE2 and productively infects mice
Julie McAuley, Uni Melbourne, Doherty Institute, VIC
#107 Identifying the neurological impact of COVID-19 in a mouse of model of SARS-CoV-2 infection
Victoria Lawson, University of Melbourne, Doherty Institute, VIC
Prevention, Epidemiology and Health Promotion
#3 COMPARING THE IMPACT OF THE COVID-19 PANDEMIC ON PEOPLE WITH HIV IN VICTORIA, AUSTRALIA OVER TWO TIME PERIODS
Mihiri Weerasuria, Monash Health, VIC
#9 AN INFODEMIC MANAGEMENT APPROACH TO SUPPORT OF HEALTH WORKERS IN PNG DURING THE COVID-19 PANDEMIC
Brooke Dickson, ASHM, NSW
#16 COVID 19 PREVENTION AMONGEST MENTALLY SICK LIVING IN THE STREETS, A CASE STUDY OF MOMBASA COUNTY KENYA
Celina Muthoni, Kithinji Mombasa County Government, Kenya
#18 Factors Associated with Uptake of COVID-19 Rapid Antigen Testing, Victoria, January – February 2022
Erica McCormick, Western Health, VIC
#21 COPING WITH COVID-19: YOUNG AUSTRALIANS’ ANXIETY AND DEPRESSION SYMPTOMS DURING THE FIRST YEAR OF THE PANDEMIC
Aimee Altermatt, Burnet Institute, VIC
#23 Approach to COVID-19 outbreak management with low testing access within a drug rehabilitation facility in Melbourne, Victoria in January 2022
Pavani Sathasivam, North East Public Health Unit (NEPHU), VIC
#25 Driving through or dropping in: how Sydney turned up for COVID-19 testing
Muzhgan Soultani, Sydney Local Health Distract, NSW
#29 PROVIDING TIMELY COMMUNITY INFORMATION THROUGH COLLABORATION: A COVID TOOLKIT ESSENTIAL
Aaron Cogle, National Association Of People With HIV Australia, NSW
#31 Assessing Local Public Health Policy Change: Loosening In-Room Quarantine to Cohort Quarantine Approach in Residential Aged Care Facilities
Emily Sotheran, Western Health, VIC
#32 A novel approach to managing a COVID-19 outbreak at a farm in remote Victoria
Jaimee Oxford, Loddon Mallee Public Health Unit, VIC
#38 Health in My Language: A gendered approach to delivering bilingual COVID-19 vaccination information and health education to migrant and refugee communities Regina Torres-Quiazon, Multicultural Centre For Women’s Health, VIC
#39 Lives saved by public health restrictions over the Victorian COVID-19 Delta variant epidemic wave, August-October 2021
Nick Scott, Burnet Institute, VIC
#47 A dynamic web-based dashboard for monitoring, synthesising, and reporting on COVID-19 pandemic in Victoria
Amadou Darboe, Department Of Health, VIC
#48 An Outbreak of COVID-19 in a Church setting – Melbourne, Victoria, December 2021
Gabrielle Hales Western Public Health Unit, Western Health, VIC
#49 Social Meaning of COVID-19 in Bangladesh Mohammed
Abul Kalam, Siam Health Care, Bangladesh
#50 Reactogenicity of Heterologous COVID-19 Vaccine Schedules: A Scoping Review
Teejay Anthony Santos, Macquarie University, NSW
#51 Characteristics of COVID-19 cases diagnosed using SARS-CoV-2 rapid antigen compared to PCR tests in Victoria, January – March 2022
Tu Quan Nguyen, Department Of Health, VIC
#52 Prevalence and epidemiological characteristics of COVID-19 reinfections in Victoria
Stephanie F. Campese, Department Of Health, VIC
#60 Modelling strategies to control COVID-19 outbreaks in the prison setting
Amy Kwon, Kirby Institute, NSW
#63 The financial cost of COVID-19 in the Australian critical care system
Stefan Court-Kowalski, Royal Adelaide Hospital, SA
#69 SURVEILLANCE TESTING USING SALIVARY RT-PCR FOR SARS-COV-2 IN MANAGED QUARANTINE FACILITIES IN AUSTRALIA: A LABORATORY VALIDATION AND IMPLEMENTATION STUDY
Mitchell Batty, The Peter Doherty Institute For Infection And Immunity, VIC
#71 A systematic review of risk factors of SARS-CoV-2 infection, by variant of concern
Matthew Harris, The University Of Melbourne, VIC
#72 DIRECTION OF AIRFLOW ON A COVID-19 WARD TO PREVENT TRANSMISSION OF AEROSOLISED RESPIRATORY PATHOGENS
Duncan Campbell, Barwon Health, VIC
#73 THE IMPACTS OF COVID-19 PANDEMIC ON DRUG PURCHASING BEHAVIOURS OF PEOPLE WHO USE METHAMPHETAMINE IN VICTORIA, MELBOURNE
Kasun Rathnayake, Burnet Institute, VIC
#84 IMPACT OF SOCIAL INFLUENCE ON RETAINING PARTICIPANTS IN AN ONLINE COVID-19 LONGITUDINAL COHORT STUDY
Aimee Altermatt, Burnet Institute, VIC
#89 An integrative CALD community response to COVID-19
Natali Smud, Diversity Programs & Strategy Hub, Population Health, Sydney Local Health District, NSW
#90 Aboriginal and Torres Strait Islander COVID-19 point-of-care testing program: Test positivity over time 2020-2022
Belinda Hengel Kirby Institute, UNSW Sydney, NSW
#91 Association between personal wellbeing and financial hardship among Victorian adults during the COVID pandemic
Aimée Altermatt, Burnet Institute, VIC
Social, Political and Cultural Aspects
#24 The shadow lockdown: strategies used by Victorians to reduce their risk of contracting COVID-19 in December 2021-January 2022
Aimée Altermatt, Burnet Institute, VIC
#26 Concerns about children returning to school in Victoria in 2022
Freya Saich, Burnet Institute, VIC
#35 LESSONS ABOUT COVID-19 VACCINE MESSAGING AND DELIVERY FOR MARGINALISED POPULATIONS/COMMUNITIES
Daniel Storer, Kirby Institute, NSW
#42 #COVIDVACCINE: AN ANALYSIS OF TRENDING CONTENT ON TIKTOK
Susan Grantham, Griffith University, QLD
#57 Riding the Delta wave in a complex community environment: The Sydney Local Health District Emergency Operations Centre response to the COVID 19 Delta wave in marginalised communities
Erin Mcsweeney, Sydney Local Health District, NSW
#74 COVID-19 Toolkit Newsletter: An innovative and responsive resource for all people living with HIV in NSW
Craig Andrews, Positive Life NSW, NSW
#87 COVID-19 Vaccine Receptivity and Preferences among Vaccine Hesitant Individuals
Seth Toback, Novavax Inc, United States
#88 All in this together? COVID responses, diverse communities and practices of care
Dean Murphy Kirby Institute, UNSW & Dept Infectious Diseases, Alfred Hospital, NSW